Mono- and Bis-Pyrimido[1,2-a]benzimidazoles
Letters in Organic Chemistry, 2011, Vol. 8, No. 9
635
[5]
[6]
[7]
AlMuhaimeed, H. A parallel-group comparison of astemizole and
loratadine for the treatment of perennial allergic rhinitis. J. Int.
Med. Res. 1997, 25, 175-181.
Richter, J. E. Long-term management of gastroesophageal reflux
disease and its complications. Am. J. Gastroenterol. 1997, 92, S30-
S34.
Evans, D.; Kicks, T. A.; Williamson, W. R.; Dawson, N.; Meaco-
cok, N. V. S. C. R.; Kitchen, E. A. Synthesis of a group of 1H-
benzimidazoles and their screening for antiinflammatory activity.
Eur. J. Med. Chem. 1996, 31, 635-642.
Ojha, V.; Singh, J.; Bhakuni, D.S.; Singh, S.; Chatterjee, R. K.
Antiparasitic agents.14. synthesis of 5-substituted 2-
carbalkoxyamino-1H-benzimidazoles as possible macrofilaricidal
agents. Indian J. Chem. 1991, 30B, 324-326.
Asobo, P. F.; Wahe, H.; Mbafor, J. T.; Nkengfack, A. E.; Fomum,
Z. T.; Sopbue, E. F.; Dopp, D. Heterocycles of biological impor-
tance. Part 5. The formation of novel biologically active
pyrimido[1,2-a]benzimidazoles from allenic nitriles and aminoben-
zimidazoles. J. Chem. Soc., Perkin Trans 2001, 1, 457-461.
Saluja, S.; Zou, R.; Drach, J. C.; Townsend, L. B. Struc-
tureꢁActivity Relationships among 2-Substituted 5,6-Dichloro-,
4,6-Dichloro-, and 4,5-Dichloro-1-[(2-hydroxyethoxy)methyl]- and
-1-[(1,3-dihydroxy-2-propoxy)methyl]benzimidazoles. J. Med.
Chem. 1996, 39, 881-891.
rom), 7.1 (1H, t, J=7.53 Hz, Harom), 7.19-7.25 (2H, m, Harom),
7.35-7.45 (2H, m, Harom), 7.53 (2H, d, J=7.94 Hz, Harom,), 8.5
(1H, s, NH). 13C NMR (DMSO-d6, 75 MHz) ꢀC: 48.73,
59.09, 112.6, 115.91, 116.30, 118.91, 120.21, 123.69,
126.51, 127.69, 127.87, 129.76, 131.06, 131.19, 132.96,
133.04, 144.01, 149.96, 151.72, 160.73, 164.04.
(4g): IR (KBr) (vmax, cm-1): 3448, 3313, 3211, 2191,
1683, 1639, 1602, 1469. 1H NMR (DMSO-d6, 300 MHz) ꢀH:
5.20 (1H, s, CH), 6.82 (1H, s, NH2), 7.0 (1H, t J=7.89 Hz,
Harom), 7.12 (2H, t, J=7.49 Hz, Harom), 7.37-7.21(6H, m, Ha-
rom), 7.62 (1H, d, J=8.03 Hz, Harom), 8.58 (1H, s, NH). Anal.
Calcd for C17H13N5: C, 71.06; H, 4.56; N, 24.37. Found: C,
71.33; H, 4.41; N, 24.44.
(4h): IR (KBr) (vmax, cm-1): 3367, 2931, 2204, 1628,
1606, 1485. 1H NMR (DMSO-d6, 300 MHz) ꢀH: 5.29 (1H, s,
CH), 6.97 (2H, s, NH2), 7.01 (1H, t, J=7.76 Hz, Harom), 7.13
(1H, t, J=7.58 Hz, Harom), 7.25-7.3 (3H, m, Harom), 7.62 (1H,
d, J=7.93 Hz, Harom), 8.45 (2H, d, J=5.98 Hz, Harom), 8.73
(1H, s, NH). Anal. Calcd for C16H12N6: C, 66.66; H, 4.20; N,
29.15. Found: C, 67.05; H, 4.24; N, 29.50.
(4i): IR (KBr) (vmax, cm-1): 3485, 3373, 3169, 2191,
1678, 1633, 1602, 1475. 1H NMR (DMSO-d6, 300 MHz) ꢀH:
5.35 (2H, s, CH), 6.91 (4H, s, NH2), 7.0 (2H, t, J=7.62 Hz,
Harom), 7.12 (2H, t, J=7.53 Hz, Harom), 7.23 (2H, d, J=7.63
Hz, Harom), 7.64 (4H, d, J=5.29 Hz, Harom), 7.87 (2H, bs,
Harom), 8.58 (2H, s, NH). Anal. Calcd for C28H22N10: C,
67.46; H, 4.45; N, 28.10. Found: C, 67.88; H, 4.61; N, 27.81.
[8]
[9]
[10]
[11]
[12]
Goker, H.; Kus, G.; Boykin, D. W.; Yildiz, S.; Altanlar, N. Altanlar
N
(2002) Synthesis of some new 2-substituted-phenyl-1H-
benzimidazole-5-carbonitriles and their potent activity against
Candida species. Bioorg. Med. Chem. 2002, 10, 2589-2596.
Goker, H.; Ayhan-Kilcigil, G. A.; Tuncbilek, M.; Kus, C.; Ertan,
R.; Kendi, E.; Ozbey, S.; Fort, M.; Garcia, C.; Farre, A. J. Synthe-
sis and antihistaminic H-1 activity of 1,2,5(6)-trisubstituted ben-
zimidazoles. Heterocycles, 1999, 51, 2561-2573.
Kumar, D.; Jacob, M. R.; Reynolds, M. B.; Kerwin, S. M. Synthe-
sis and evaluation of anticancer benzoxazoles and benzimidazoles
related to UK-1. Bioorg. Med. Chem. 2002, 10, 3997-4004.
Kubo, K.; Inada, Y.; Kohara, Y.; Sugiuers, Y.; Mamiojima, Itoh,
K.; Furukawa, Y.; Nighlugaky, K.; Takehiko. Nonpeptide angio-
tensin II receptor antagonists. Synthesis and biological activity of
benzimidazoles. J. Med. Chem. 1993, 36, 1772-1784.
Rodriguez, M. L. L.; Benhamu, B.; Viso, A.; Morcillo, M. J.; Mur-
cia, M.; Orensanz, L.; Alfaro, M. J.; Martin, M. I. Benzimidazole
derivatives. Part 1: Synthesis and structure-activity relationships of
new benzimidazole-4-carboxamides and carboxylates as potent and
selective 5-HT4 receptor antagonists. Bioorg. Med. Chem. 1999, 7,
2271-2281.
Sharma, S.; Abuzar, S. The benzimidazole anthelmintics--
chemistry and biological activity. Prog. Drug. Res. 1983, 27, 85-
161.
Garuti, L.; Roberti, M.; Malagoli, M.; Rossi, T.; Castelli, M. Syn-
thesis and antiproliferative activity of some benzimidazole-4,7-
dione derivatives. Bioorg. Med. Chem. Lett. 2000, 10, 2193-2195.
Nawrocka, W.; Sztuba, B.; Kowalska, M. W.; Liszkiewicz, H.;
Wietrzyk, J.; Nasulewicz, A.; Pelczynska, M.; Opolski, A. Synthe-
sis and antiproliferative activity in vitro of 2-aminobenzimidazole
derivatives. Farmaco 2004, 59, 83-91.
(a) Komykhov, S. A.; Ostras, K. S.; Kostanyan, A. R.; Desenko, S.
M.; Orlov, V. D.; Meier, H. The reaction of amino-imidazoles, -
pyrazoles and -triazoles with alpha,beta-unsaturated nitriles. J.
Heterocycl. Chem. 2005, 42, 1111-1116. (b) Karci, F.; Demirçalı,
A.; Sener, ꢂ.; Tilki, T. Synthesis of 4-amino-1H-
benzo[4,5]imidazo[1,2-a]pyrimidin-2-one and its disperse azo dyes.
Part 1: Phenylazo derivatives. Dyes and Pigments 2006, 71, 90-96.
Wahe, H.; Asobo, P. F.; Cherkasov, R. A.; Fomum, Z. T.; Doepp,
D. Heterocycles of biological importance: Part 8. Formation of
pyrimido[1,2-a]benzimidazoles and oxazolo[3,2-a]benzimidazoles
by conjugate addition of 2-aminobenzimidazoles to 4-hydroxy-2-
alkynenitriles. Arkivoc 2004, (i), 130-137. (b) Wahe, H.; Asobo, P.
F.; Cherkasov, R. A.; Nkengfack, A. E.; Folefoc, G. N.; Fomum, Z.
T.; Doepp, D. Heterocycles of Biological Importance: Part 6. The
formation of novel biologically active pyrimido[1,2-alpha] ben-
zimidazoles from electron deficient alkynes and 2-
aminobenzimidazoles. Arkivoc 2003 (xiv) 170-177.
[13]
[14]
(4j): IR (KBr) (vmax, cm-1): 3412, 3288, 3086, 2185,
1682, 1631, 1589, 1473. 1H NMR (DMSO-d6, 300 MHz) ꢀH:
5.36 (2H, s, CH), 6.93 (4H, s, NH2), 7.0 (2H, t, J=7.5 Hz,
Harom), 7.13 (2H, t, J=7.53 Hz, Harom), 7.25 (2H, d, J=8.09
Hz, Harom), 7.51 (2H, d, J=8.28 Hz, Harom), 7.62 (2H, d,
J=7.96 Hz, Harom), 7.93 (2H, d, J=8.29 Hz, Harom), 8.51 (2H,
s, NH). Anal. Calcd for C28H22N10: C, 67.46; H, 4.45; N,
28.10. Found: C, 67.79; H, 4.32; N, 28.30.
[15]
[16]
[17]
[18]
ACKNOWLEDGEMENT
We gratefully acknowledge the financial support from
the Research Council of Arak University.
SUPPLEMENTARY MATERIAL
[19]
[20]
Supplementary material is available on the publishers
Web site along with the published article.
REFERENCES
[1]
Hulme, C.; Gore, V. "Multi-component reactions: Emerging chem-
istry in drug discovery" 'From xylocain to crixivan'. Curr. Med.
Chem. 2003, 10, 51-80.
[2]
Lage, H. ; Aki-Sener, E.; Yalcin, I. High antineoplastic activity of
new heterocyclic compounds in cancer cells with resistance against
classical DNA topoisomerase II-targeting drugs. Int. J. Cancer
2006, 119, 213-220.
[3]
[4]
Winstanley, P. Albendazole for mass treatment of asymptomatic
trichuris infections. Lancet 1998, 352, 1080-1081.
Carpio, A. Albendazole therapy for subarachnoid cysticerci: clini-
cal and neuroimaging analysis of 17 patients. J. Neurol. Neurosurg.
Psychiat. 1999, 66, 411-412.
[21]
Shaabani, A.; Rahmati, A.; Rezayan, A. H.; Darvishi, M.; Badri,
Z.; Sarvari, A. Clean synthesis in water: Uncatalyzed three-
component condensation reaction of 3-amino-1,2,4-triazole or 2-
aminobenzimidazole with aldehyde in the presence of activated
CH-Acids. QSAR Comb. Sci. 2007, 26, 973-979. (b) Liu, G.; Shao,